In a variety of tumor cells, including gastric cancer, glioblastoma, and breast cancer, the activation of the CXCL12/CXCR4 axis has been observed to stimulate the SRC, ERK, and STAT3 pathways. Here, CXCR4 is linked to neoplasm.